Financhill
Sell
38

SVA Quote, Financials, Valuation and Earnings

Last price:
$6.47
Seasonality move :
4.38%
Day range:
$6.47 - $6.47
52-week range:
$6.47 - $6.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.50x
P/B ratio:
0.62x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$464.9M
Revenue:
$448.3M
EPS (TTM):
-$1.31

Earnings Data

Next earnings date for SVA
--
Most recent earnings per share
$0.96
Beat by $0.96
(Dec 31/2020)
Consensus Estimate
--
(Dec 31/2020)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SVA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2020 Q4 -- -- $0.96 -- --
12/07/2020 Q3 -- -- $0.10 -- --
08/28/2020 Q2 -- -- -$0.05 -- --
04/30/2020 Q1 -- -- -$0.07 -- --
12/31/2019 Q4 -- -- $0.20 -- --
11/15/2019 Q3 -- -- $0.06 -- --
07/10/2019 Q2 -- -- $0.11 -- --
04/29/2019 Q1 -- -- $0.01 -- --
12/31/2018 Q4 -- -- -$0.03 -- --
11/08/2018 Q3 -- -- $0.12 -- --
06/30/2018 Q2 -- -- $0.10 -- --
05/11/2018 Q1 -- -- $0.14 -- --
12/31/2016 Q4 -- -- $0.09 -- --
11/28/2016 Q3 -- -- $0.06 -- --
08/23/2016 Q2 -- -- -$0.17 -- --
04/05/2016 Q1 -- -- $0.02 -- --
12/31/2015 Q4 -- -- -- -- --

Sinovac Biotech Ltd. Earnings Questions

  • How Much did Sinovac Biotech Ltd. Generate in Revenue Last Quarter?

    Sinovac Biotech Ltd. reported -- worth of top line sales in its most recent quarter.

  • Did Sinovac Biotech Ltd. Beat Earnings Last Quarter?

    Sinovac Biotech Ltd. announced earnings per share of $0.96 which represents a beat of analyst forecast a -- per share.

  • Is Sinovac Biotech Ltd. Profitable?

    Sinovac Biotech Ltd. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Sinovac Biotech Ltd. EPS Next Year?

    Sinovac Biotech Ltd.'s earnings are forecast to grow from -$1.06 per share to -- per share next year representing an increase of --.

  • When is Sinovac Biotech Ltd.'s Earnings Date?

    Currently, Sinovac Biotech Ltd. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 23

Applied Optoelectronics, Inc. [AAOI] is up 4.51% over the past day.

Buy
52
ABVX alert for Dec 23

Abivax SA [ABVX] is up 0.04% over the past day.

Buy
60
ZBIO alert for Dec 23

Zenas BioPharma, Inc. [ZBIO] is down 0.54% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock